Skip to main content
Premium Trial:

Request an Annual Quote

The Close Genome and Neuroscience

Actress Glenn Close says her genome shows that she is "fabulous, sexy, and divinely complex," according to the New Scientist. Close had her genome sequenced earlier this year in part to help determine the genetic causes of mental disease, as mental illnesses run in her family. At the annual Society for Neuroscience meeting, she spoke about her genome as well as the need to remove the stigma from mental illness at the annual Society for Neuroscience meeting. Close also recently founded a not-for-profit organization, called BringChange2Mind, with the aim of ending that stigma. Her sister and nephew also took to the stage to describe their experiences with bipolar disorder and schizoaffective disorder, respectively. "You're saving lives. Thank you," Close said to the crowd at the conference, according to Nature's The Great Beyond.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.